Alle berichten over deze gebeurtenis, automatisch gegroepeerd uit meerdere onafhankelijke bronnen.
Laatst bijgewerkt: 8 september 2026 om 13:03 · 6 artikelen · 2 bronnen
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
Lees bij CNBC · 8 september 2026 om 12:32
These positive results could open up a new way to treat serious lung disease.
Lees bij STAT News · 8 september 2026 om 10:00
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Lees bij CNBC · 8 september 2026 om 09:23
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
Lees bij STAT News · 8 september 2026 om 08:30
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a matter of days.
Lees bij STAT News · 8 september 2026 om 07:28
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
Lees bij CNBC · 8 september 2026 om 05:00